These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 28719435

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cutaneous vasculitis induced by TNF inhibitors: a report of three cases.
    Fujikawa K, Kawakami A, Hayashi T, Iwamoto N, Kawashiri SY, Aramaki T, Ichinose K, Tamai M, Arima K, Kamachi M, Yamasaki S, Nakamura H, Ida H, Origuchi T, Eguchi K.
    Mod Rheumatol; 2010 Feb; 20(1):86-9. PubMed ID: 19812889
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Leukocytoclastic vasculitis due to etanercept.
    Galaria NA, Werth VP, Schumacher HR.
    J Rheumatol; 2000 Aug; 27(8):2041-4. PubMed ID: 10955351
    [Abstract] [Full Text] [Related]

  • 5. Leukocytoclastic vasculitis complicating adalimumab therapy for Crohn's disease: Report of three cases.
    Bernardes C, Carvalho D, Saiote J, Ramos J.
    Gastroenterol Hepatol; 2018 Aug; 41(7):442-443. PubMed ID: 29054318
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Clemente RE.
    Scand J Rheumatol; 2007 Aug; 36(3):244-5; author reply 245. PubMed ID: 17657687
    [No Abstract] [Full Text] [Related]

  • 8. Dermatologic perivascular hemophagocytosis: a report of two cases.
    Draper NL, Morgan MB.
    Am J Dermatopathol; 2007 Oct; 29(5):467-9. PubMed ID: 17890916
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rituximab-induced vasculitis: A case report and review of the medical published work.
    Kim MJ, Kim HO, Kim HY, Park YM.
    J Dermatol; 2009 May; 36(5):284-7. PubMed ID: 19382999
    [Abstract] [Full Text] [Related]

  • 12. Cutaneous necrotizing vasculitis after low dose methotrexate therapy for rheumatoid arthritis: a possible manifestation of methotrexate hypersensitivity.
    Simonart T, Durez P, Margaux J, Van Geertruyden J, Goldschmidt D, Parent D.
    Clin Rheumatol; 1997 Nov; 16(6):623-5. PubMed ID: 9456017
    [Abstract] [Full Text] [Related]

  • 13. Cutaneous vasculitis associated with infliximab in the treatment of rheumatoid arthritis.
    Anandacoomarasamy A, Kannangara S, Barnsley L.
    Intern Med J; 2005 Oct; 35(10):638-40. PubMed ID: 16207269
    [No Abstract] [Full Text] [Related]

  • 14. TNF-inhibitor induced lupus in a patient treated with adalimumab for rheumatoid arthritis.
    Lieberman MR, Liebman TN, Alapati U, Khachemoune A.
    Dermatol Online J; 2014 Dec 13; 21(2):. PubMed ID: 25756476
    [Abstract] [Full Text] [Related]

  • 15. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Martínez-Taboada VM, Val-Bernal JF, Pesquera LC, Fernández-Llanio NE, Esteban JM, Blanco R, Alonso-Bartolome P, Gonzalez-Vela C, Rodríguez-Valverde V.
    Scand J Rheumatol; 2006 Dec 13; 35(4):322-3. PubMed ID: 16882599
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Perivascular hemophagocytosis: report of 2 cases and review of the literature.
    Valentín SM, Montalván E, Sánchez JL.
    Am J Dermatopathol; 2010 Oct 13; 32(7):716-9. PubMed ID: 20859080
    [Abstract] [Full Text] [Related]

  • 19. Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept.
    Mor A, Bingham CO, Barisoni L, Lydon E, Belmont HM.
    J Rheumatol; 2005 Apr 13; 32(4):740-3. PubMed ID: 15801034
    [Abstract] [Full Text] [Related]

  • 20. Leukocytoclastic vasculitis induced by low-dose methotrexate: in vitro evidence for an immunologic mechanism.
    Halevy S, Giryes H, Avinoach I, Livni E, Sukenik S.
    J Eur Acad Dermatol Venereol; 1998 Jan 13; 10(1):81-5. PubMed ID: 9552765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.